UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cytotoxic effects of MgO nanoparticles on human umbilical vein endothelial cells in vitro

IET nanobiotechnology, 2011-06, Vol.5 (2), p.36-40

2011

Volltextzugriff (PDF)

Effect of sugar positions in ginsenosides and their inhibitory potency on Na^＋/K^＋-ATPase activity

Acta pharmacologica Sinica, 2009-01, Vol.30 (1), p.61-69

2009

Volltextzugriff (PDF)

Enhancing the potency of lithospermate B for inhibiting Na＋/K＋-ATPase activity by forming transition metal ion complexes

Acta pharmacologica Sinica, 2013-07, Vol.34 (7), p.893-900

2013

Volltextzugriff (PDF)

Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress

Acta pharmacologica Sinica, 2022-03, Vol.43 (3), p.645-658

2022

Volltextzugriff (PDF)

Protein tyrosine phosphatases as potential therapeutic targets

Acta pharmacologica Sinica, 2014-10, Vol.35 (10), p.1227-1246

2014

Volltextzugriff (PDF)

Integrating endocannabinoid signaling in the regulation of anxiety and depression

Acta pharmacologica Sinica, 2019-03, Vol.40 (3), p.336-341

2019

Volltextzugriff (PDF)

TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer

Acta pharmacologica Sinica, 2022-03, Vol.43 (3), p.681-691

2022

Volltextzugriff (PDF)

Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury： involvement of PI3 kinase signal pathway

Acta pharmacologica Sinica, 2009-02, Vol.30 (2), p.159-165

2009

Volltextzugriff (PDF)

A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors

Acta pharmacologica Sinica, 2022-02, Vol.43 (2), p.483-493

2022

Volltextzugriff (PDF)

Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation

Acta pharmacologica Sinica, 2022-04, Vol.43 (4), p.771-780

2022

Volltextzugriff (PDF)

Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells

Acta pharmacologica Sinica, 2022-01, Vol.43 (1), p.240-250

2022

Volltextzugriff (PDF)

Nanoengineered targeting strategy for cancer immunotherapy

Acta pharmacologica Sinica, 2020-07, Vol.41 (7), p.902-910

2020

Volltextzugriff (PDF)

CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia

Acta pharmacologica Sinica, 2022-01, Vol.43 (1), p.121-132

2022

Volltextzugriff (PDF)

Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis

Acta pharmacologica Sinica, 2019-12, Vol.40 (12), p.1568-1577

2019

Volltextzugriff (PDF)

Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20＋ melanoma stem cells

Acta pharmacologica Sinica, 2018-02, Vol.39 (2), p.261-274

2018

Volltextzugriff (PDF)

Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence

Acta pharmacologica Sinica, 2020-01, Vol.41 (1), p.1-9

2020

Volltextzugriff (PDF)

The dual function of cGAS-STING signaling axis in liver diseases

Acta pharmacologica Sinica, 2024-06, Vol.45 (6), p.1115-1129

2024

Volltextzugriff (PDF)

RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination

Acta pharmacologica Sinica, 2020-03, Vol.41 (3), p.394-403

2020

Volltextzugriff (PDF)

Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer

Acta pharmacologica Sinica, 2021-08, Vol.42 (8), p.1298-1310

2021

Volltextzugriff (PDF)

SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

Acta pharmacologica Sinica, 2021-06, Vol.42 (6), p.998-1004

2021

Volltextzugriff (PDF)

PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis

Acta pharmacologica Sinica, 2023-02, Vol.44 (2), p.454-464

2023

Volltextzugriff (PDF)

DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivo

Acta pharmacologica Sinica, 2021-09, Vol.42 (9), p.1498-1506

2021

Volltextzugriff (PDF)

Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage： a systematic review and meta-analysis

Acta pharmacologica Sinica, 2015-06, Vol.36 (6), p.659-675

2015

Volltextzugriff (PDF)

FK228 potentiates topotecan activity against small cell lung cancer cells via induction of SLFN11

Acta pharmacologica Sinica, 2022-08, Vol.43 (8), p.2119-2127

2022

Volltextzugriff (PDF)

Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer

Acta pharmacologica Sinica, 2024-06, Vol.45 (6), p.1264-1275

2024

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Aktive Filter

ThemaMale

KollektionNexis Uni

KollektionWiley Online Library

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(98)

Sprache

Englisch
(98)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(86)
Science & Technology
(86)
Chemistry
(84)
Chemistry, Multidisciplinary
(84)
Pharmacology & Pharmacy
(84)
Physical Sciences
(84)
Animals
(53)
Original
(35)
Cell Line, Tumor
(29)
Mice
(19)
Apoptosis
(15)
Antineoplastic Agents - Pharmacology
(13)
Cells, Cultured
(13)
Dose-Response Relationship, Drug
(13)
Female
(13)
Apoptosis - Drug Effects
(11)
Cell Line
(11)
Cell Survival - Drug Effects
(11)
Mice, Nude
(11)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

4 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Cytotoxic effects of MgO nanoparticles on human umbilical vein endothelial cells in vitro

Effect of sugar positions in ginsenosides and their inhibitory potency on Na^＋/K^＋-ATPase activity

Enhancing the potency of lithospermate B for inhibiting Na＋/K＋-ATPase activity by forming transition metal ion complexes

Blueberry-derived exosomes-like nanoparticles ameliorate nonalcoholic fatty liver disease by attenuating mitochondrial oxidative stress

Protein tyrosine phosphatases as potential therapeutic targets

Integrating endocannabinoid signaling in the regulation of anxiety and depression

TRIM25 activates AKT/mTOR by inhibiting PTEN via K63-linked polyubiquitination in non-small cell lung cancer

Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury： involvement of PI3 kinase signal pathway

A multi-targeting drug design strategy for identifying potent anti-SARS-CoV-2 inhibitors

Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation

Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells

Nanoengineered targeting strategy for cancer immunotherapy

CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia

Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis

Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20＋ melanoma stem cells

Neural circuits and nicotinic acetylcholine receptors mediate the cholinergic regulation of midbrain dopaminergic neurons and nicotine dependence

The dual function of cGAS-STING signaling axis in liver diseases

RNF6 promotes myeloma cell proliferation and survival by inducing glucocorticoid receptor polyubiquitination

Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer

SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis

DW14383 is an irreversible pan-FGFR inhibitor that suppresses FGFR-dependent tumor growth in vitro and in vivo

Promoting blood circulation for removing blood stasis therapy for acute intracerebral hemorrhage： a systematic review and meta-analysis

FK228 potentiates topotecan activity against small cell lung cancer cells via induction of SLFN11

Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer

Aktive Filter

Suchergebnisse filtern